Happy Hour: Real Contrarian

·

A lot of people claim to be contrarian, but few actually are. Either, they think they’re unique in having an idea, even though everyone shares it. Or they claim it but never act.

Take Valeant Pharmaceuticals. First, imagine a stock rising to lofty heights – about $262 – from a 2009 low around $11. Had you bought it at any point before June 2015, you would have made money.

Then August came with bad news and the hits just kept on coming. The stock collapsed 87% from its highs to $35.

VRX chart

I doubt many people will look at that chart and think opportunity. It’s a picture of a loathed and ostracized stock. Each dip was another round of terrible news.

Valeant has been the poster child of every mistake possible – catching a falling knife, over-concentration, holding on too long, the errors of leverage, accounting fraud – but a stock’s story doesn’t end until it hits zero. There are several potential outcomes – most don’t end well for shareholders. Maybe there’s redemption. Maybe it’s zero. Who know. I sure don’t.

But saying you’re a contrarian means looking at and jumping headfirst (ok, maybe just dipping a toe – ankle deep at most – in Valeant’s case) into that muck because that is the pool that real contrarians play in. I doubt many people can do that. It certainly doesn’t look easy or comfortable.

Reminder: The Berkshire annual meeting is tomorrow. For the first time ever you can sit on your couch and tune in. Yahoo Finance is hosting live coverage of the event starting at 10:00am ET. An on-demand replay will be available for 30 days. And I’ll post notes sometime in the next week or two.

Last Call


Get more weekly wisdom.

Sign up for my weekly newsletter. Join 1,000s of readers and never miss a post.

Newsletter Subscribe Form

Work with Me

Financial Planning

Investment Management

Portfolio Review